Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BrigHTN: Baxdrostat for Treatment-Resistant Hypertension
NCT04519658Phase 2Completed
- Sponsor
- CinCor Pharma
- Start
- Oct 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of baxdrostat in hypertension (HTN), sponsored by CinCor Pharma. Started Oct 2020; status: completed.
02
Drugs
baxdrostat
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04519658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04519658.